60 related articles for article (PubMed ID: 6825534)
1. Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis.
Martinez-Gili L; Pechlivanis A; McDonald JAK; Begum S; Badrock J; Dyson JK; Jones R; Hirschfield G; Ryder SD; Sandford R; Rushbrook S; Thorburn D; Taylor-Robinson SD; Crossey MME; Marchesi JR; Mells G; Holmes E; Jones D
Gut Microbes; 2023; 15(1):2208501. PubMed ID: 37191344
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Metabolomics Study of the Bile Acid Pathway During Perioperative Primary Hepatic Carcinoma Following Liver Transplantation.
Sui W; Gan Q; Liu F; Ou M; Wang B; Liao S; Lai L; Chen H; Yang M; Dai Y
Ann Transplant; 2020 Jun; 25():e921844. PubMed ID: 32572018
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes of key metabolites during liver fibrosis in rats.
Yu J; He JQ; Chen DY; Pan QL; Yang JF; Cao HC; Li LJ
World J Gastroenterol; 2019 Feb; 25(8):941-954. PubMed ID: 30833800
[TBL] [Abstract][Full Text] [Related]
4. Pharmacometabolomic prediction of individual differences of gastrointestinal toxicity complicating myelosuppression in rats induced by irinotecan.
Gao Y; Li W; Chen J; Wang X; Lv Y; Huang Y; Zhang Z; Xu F
Acta Pharm Sin B; 2019 Jan; 9(1):157-166. PubMed ID: 30766787
[TBL] [Abstract][Full Text] [Related]
5. Analytical evaluation of three enzymatic assays for measuring total bile acids in plasma using a fully-automated clinical chemistry platform.
Danese E; Salvagno GL; Negrini D; Brocco G; Montagnana M; Lippi G
PLoS One; 2017; 12(6):e0179200. PubMed ID: 28594875
[TBL] [Abstract][Full Text] [Related]
6. A synthetic biology-based device prevents liver injury in mice.
Bai P; Ye H; Xie M; Saxena P; Zulewski H; Charpin-El Hamri G; Djonov V; Fussenegger M
J Hepatol; 2016 Jul; 65(1):84-94. PubMed ID: 27067456
[TBL] [Abstract][Full Text] [Related]
7. Reference intervals for preprandial and postprandial serum bile acid in adult rhesus macaques (Macaca mulatta).
Lemoy MJ; Westworth DR; Ardeshir A; Tarara RP
J Am Assoc Lab Anim Sci; 2013 Jul; 52(4):444-7. PubMed ID: 23849441
[TBL] [Abstract][Full Text] [Related]
8. Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers.
Ijaz B; Ahmad W; Javed FT; Gull S; Hassan S
Virol J; 2011 Feb; 8():86. PubMed ID: 21352567
[TBL] [Abstract][Full Text] [Related]
9. Individual serum bile acids in apprentice spray painters in association with solvent exposure.
Liu JJ; Bai CL; Williamson AM; Qu SX; Hamdan H; Stacey NH
Int Arch Occup Environ Health; 1996; 69(1):21-6. PubMed ID: 9017430
[TBL] [Abstract][Full Text] [Related]
10. Colorimetric enzymatic measurement of serum total 3 alpha-hydroxy bile acid concentrations without extraction.
Qureshi MY; Smith SM; Murphy GM
J Clin Pathol; 1984 Mar; 37(3):317-20. PubMed ID: 6583208
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease.
Scott NR; Stambuk D; Chakraborty J; Marks V; Morgan MY
Br J Clin Pharmacol; 1989 Feb; 27(2):205-13. PubMed ID: 2713214
[TBL] [Abstract][Full Text] [Related]
12. Measurement of bile acid half-life using [75Se]HCAT in health and intestinal diseases. Comparison with [75Se]HCAT abdominal retention methods.
Ferraris R; Galatola G; Barlotta A; Pellerito R; Fracchia M; Cottino F; de la Pierre M
Dig Dis Sci; 1992 Feb; 37(2):225-32. PubMed ID: 1735340
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of serum bile acids and routine liver function tests in hepatobiliary diseases. Sensitivity, specificity, and predictive value.
Ferraris R; Colombatti G; Fiorentini MT; Carosso R; Arossa W; De La Pierre M
Dig Dis Sci; 1983 Feb; 28(2):129-36. PubMed ID: 6825534
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of serum immunoreactive conjugated cholic or chenodeoxycholic acids in detecting hepatobiliary diseases. Comparison with levels of 3 alpha-hydroxy bile acids determined enzymatically and with routine liver tests.
Ferraris R; Fiorentini MT; Galatola G; Rolfo P; De la Pierre M
Dig Dis Sci; 1987 Aug; 32(8):817-23. PubMed ID: 3608729
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of the concentration in serum of total 3 alpha-hydroxy bile acids in the diagnosis of hepatobiliary disease.
Linnet K; Kelbaek H; Frandsen P
Scand J Gastroenterol; 1982 Mar; 17(2):263-8. PubMed ID: 7134852
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of twelve-hour preprandial and two-hour postprandial serum bile acids concentrations for diagnosis of hepatobiliary disease in dogs.
Center SA; ManWarren T; Slater MR; Wilentz E
J Am Vet Med Assoc; 1991 Jul; 199(2):217-26. PubMed ID: 1890031
[TBL] [Abstract][Full Text] [Related]
17. Serum bile acids in hepatobiliary disease.
Bouchier IA; Pennington CR
Gut; 1978 Jun; 19(6):492-6. PubMed ID: 355064
[TBL] [Abstract][Full Text] [Related]
18. Advances in the application of biochemical tests to diseases of the liver and biliary tract: their role in diagnosis, prognosis, and the elucidation of pathogenetic mechanisms.
Goldberg DM; Brown D
Clin Biochem; 1987 Apr; 20(2):127-48. PubMed ID: 3301064
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
